Coronavirus: Would You Choose to Be Vaccinated?

Coronavirus: Would You Choose to Be Vaccinated?

Various festivals are coming, and the epidemic obviously cannot stop people’s enthusiasm for celebrating festivals. In the UK, where the epidemic has rebounded again in time, young people are still holding various raves before the possible lockdown again. In the face of an unpredictable epidemic, the world is looking forward to the emergence of vaccines. At least from the current situation, vaccines will be the last resort to control and solve the new coronavirus.

When will the vaccine come?

Although President Trump has a good plan, he is looking forward to an October-surprises to boost his election. However, whether this plan is feasible or not, experts from the US CDC, including Dr. Fauci, disagree. Dr. Fauci emphasized on many occasions the scientific steps of vaccine development and the importance of vaccine safety. According to the current vaccine development progress of research institutes in various countries, no organization can be 100% confident that the vaccine will be approved for use in October.

Whether it is China or Europe, the United States or other countries in the world, there will be a major expectation. The expectation is that by the end of this year, many vaccines claim that they will be on the market.

The reason people look forward to the arrival of vaccines is that vaccines bring huge possibilities to global interoperability. People hope to obtain global herd immunity through vaccines, thereby realizing world interoperability.

More than that, with the launch of vaccines, many problems may be gradually solved. For example, the mortality and mortality rate caused by the new coronavirus will drop significantly to the acceptable range.

Is the vaccine effective enough?

Experts believe that the safety and effectiveness of vaccines need to be evaluated for a full year in 2021, which means that this time point (when the vaccine arrives) may be delayed for a while, and it will not be the end of the year or the beginning of next year.

The vaccine that can be injected has not yet completed the Phase III clinical trial study, which is an emergency vaccination of the vaccine. The Phase III clinical study is actually of great significance. The study will compare two very large groups of people (have been vaccinated and not vaccinated). For example, every adverse reaction of a person who has been vaccinated will not be treated. People who use the vaccine can do a control, and in the end they will find out which adverse reactions of the vaccine are related to the vaccine.

The results of the third phase of the vaccine clinical study will also provide people with a key data-the vaccine protection rate and the incidence of adverse reactions.

Iceland conducted antibody tracking tests on more than 1,000 infected people for 4 months, and the results showed that these people’s antibodies remained at a very stable level after 4 months. China has also continuously monitored the antibody levels of participants in inactivated vaccine trials for several months. The monitoring results also show that the levels of neutralizing antibodies induced by inactivated vaccines have always maintained a high and stable level.

The results of these studies are good signs, meaning that whether it is natural infection or vaccination, it can provide effective and stable antibodies. So far, the performance of the new coronavirus is still a normal virus, and there has not been a very rapid mutation or rapid decline of the human body’s immunity to it.

Would You Choose to Be Vaccinated?

Whether to vaccinate or not depends on the judgment of each person and the judgment of the new crown epidemic situation in their country or destination country. Regardless of the impact of cultural and religious differences, after the vaccine is approved for marketing, whether to choose to vaccinate for immunization, you can consider the following points:

  1. The epidemic situation in your country or destination country. If the epidemic continues to remain at a relatively serious level, then choosing vaccination is a more effective way to protect yourself;
  2. The protection rate and adverse reaction rate of the vaccine’s own Phase III clinical trial; these data can be used to determine which vaccine to choose for injection;
  3. Vaccine price factors. Undeniably, price is still a determining factor in many cases. The price of a vaccine that has spent huge resources and costs on research should not be too cheap.

Considering the above three factors, combined with your own situation, decide whether to receive the vaccine.

Conclusion:

Regardless of whether the vaccine is administered or not, the necessary protective measures cannot be abandoned until the new crown epidemic is completely controlled. Don’t give up self-protection just because of the vaccine. Protective measures such as frequent hand washing and maintaining safe social distancing are still very important means.